We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » S-P LAUNCHES GENERIC REBETOL; MARKET UNCERTAIN
S-P LAUNCHES GENERIC REBETOL; MARKET UNCERTAIN
April 20, 2004
Drugmaker Schering-Plough has launched a generic version of its own hepatitis C drug Rebetol (ribavirin) — a move that some analysts say could destroy the market for generic firms already selling the product.